Fidelity Investments’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$122M Sell
424,240
-720,363
-63% -$207M 0.01% 1032
2025
Q1
$353M Sell
1,144,603
-326,802
-22% -$101M 0.02% 586
2024
Q4
$519M Buy
1,471,405
+393,777
+37% +$139M 0.03% 457
2024
Q3
$386M Buy
1,077,628
+314,004
+41% +$113M 0.02% 569
2024
Q2
$243M Sell
763,624
-253,987
-25% -$80.9M 0.02% 719
2024
Q1
$234M Sell
1,017,611
-1,303,429
-56% -$299M 0.02% 733
2023
Q4
$510M Sell
2,321,040
-283,749
-11% -$62.4M 0.04% 418
2023
Q3
$588M Sell
2,604,789
-11,567
-0.4% -$2.61M 0.05% 336
2023
Q2
$578M Buy
2,616,356
+78,899
+3% +$17.4M 0.05% 381
2023
Q1
$568M Sell
2,537,457
-49,347
-2% -$11.1M 0.05% 367
2022
Q4
$719M Sell
2,586,804
-390,455
-13% -$109M 0.07% 276
2022
Q3
$623M Buy
2,977,259
+284,870
+11% +$59.6M 0.07% 289
2022
Q2
$634M Sell
2,692,389
-16,529
-0.6% -$3.89M 0.06% 286
2022
Q1
$486M Buy
2,708,918
+185,540
+7% +$33.3M 0.04% 451
2021
Q4
$545M Buy
2,523,378
+199,583
+9% +$43.1M 0.04% 429
2021
Q3
$429M Sell
2,323,795
-23,949
-1% -$4.42M 0.03% 491
2021
Q2
$421M Sell
2,347,744
-177,404
-7% -$31.8M 0.03% 500
2021
Q1
$422M Buy
2,525,148
+202,465
+9% +$33.9M 0.04% 487
2020
Q4
$353M Sell
2,322,683
-245,333
-10% -$37.2M 0.03% 515
2020
Q3
$259M Buy
2,568,016
+50,970
+2% +$5.15M 0.03% 543
2020
Q2
$305M Buy
2,517,046
+8,187
+0.3% +$991K 0.03% 454
2020
Q1
$238M Buy
2,508,859
+125,310
+5% +$11.9M 0.03% 448
2019
Q4
$210M Buy
2,383,549
+201,569
+9% +$17.8M 0.02% 629
2019
Q3
$174M Sell
2,181,980
-294,296
-12% -$23.5M 0.02% 672
2019
Q2
$193M Sell
2,476,276
-212,427
-8% -$16.6M 0.02% 646
2019
Q1
$316M Sell
2,688,703
-181,821
-6% -$21.3M 0.04% 466
2018
Q4
$313M Sell
2,870,524
-65,877
-2% -$7.17M 0.04% 418
2018
Q3
$376M Sell
2,936,401
-582,063
-17% -$74.4M 0.04% 428
2018
Q2
$398M Sell
3,518,464
-310,312
-8% -$35.1M 0.05% 397
2018
Q1
$430M Sell
3,828,776
-137,350
-3% -$15.4M 0.05% 385
2017
Q4
$587M Sell
3,966,126
-247,164
-6% -$36.6M 0.07% 309
2017
Q3
$494M Sell
4,213,290
-41,551
-1% -$4.87M 0.06% 333
2017
Q2
$552M Buy
4,254,841
+116,062
+3% +$15.1M 0.07% 297
2017
Q1
$560M Buy
4,138,779
+98,529
+2% +$13.3M 0.07% 289
2016
Q4
$579M Buy
4,040,250
+11,842
+0.3% +$1.7M 0.08% 277
2016
Q3
$476M Sell
4,028,408
-32,946
-0.8% -$3.89M 0.06% 324
2016
Q2
$430M Sell
4,061,354
-382,844
-9% -$40.6M 0.06% 352
2016
Q1
$495M Buy
4,444,198
+32,829
+0.7% +$3.66M 0.07% 298
2015
Q4
$691M Buy
4,411,369
+441,595
+11% +$69.2M 0.09% 220
2015
Q3
$521M Buy
3,969,774
+328,441
+9% +$43.1M 0.07% 285
2015
Q2
$633M Sell
3,641,333
-742,523
-17% -$129M 0.08% 273
2015
Q1
$756M Buy
4,383,856
+423,488
+11% +$73M 0.1% 237
2014
Q4
$513M Sell
3,960,368
-141,028
-3% -$18.3M 0.07% 329
2014
Q3
$528M Sell
4,101,396
-394,145
-9% -$50.7M 0.07% 302
2014
Q2
$398M Sell
4,495,541
-1,285,847
-22% -$114M 0.05% 396
2014
Q1
$544M Buy
5,781,388
+524,101
+10% +$49.3M 0.08% 287
2013
Q4
$594M Buy
5,257,287
+447,380
+9% +$50.6M 0.08% 265
2013
Q3
$379M Sell
4,809,907
-27,191
-0.6% -$2.14M 0.06% 374
2013
Q2
$318M Buy
+4,837,098
New +$318M 0.05% 406